Haemonetics Aktie
WKN: 881782 / ISIN: US4050241003
04.11.2020 12:14:34
|
Haemonetics Q2 Results Top Estimates - Quick Facts
(RTTNews) - Healthcare company Haemonetics Corp. (HAE) reported Tuesday that net income for the second quarter grew to $48.10 million or $0.94 per share from $37.49 million or $0.72 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.62 per share, compared to last year's $0.87 per share.
Net revenue for the quarter decreased 17.1 percent to $209.49 million from last year's $252.57 million, primarily driven by the continued negative impact of COVID-19. Organic revenue was down 15.5 percent.
On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.51 per share on revenue of $207.65 million for the quarter. Analysts' estimates typically exclude special items.
Looking ahead, the company said it did not issue fiscal 2021 guidance due to the continued uncertainty about the pace and timing of the COVID-19 pandemic and recovery.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Haemonetics Corp.mehr Nachrichten
07.05.25 |
Ausblick: Haemonetics präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
23.04.25 |
Erste Schätzungen: Haemonetics verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
05.02.25 |
Ausblick: Haemonetics informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
22.01.25 |
Erste Schätzungen: Haemonetics stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu Haemonetics Corp.mehr Analysen
Aktien in diesem Artikel
Haemonetics Corp. | 59,00 | 0,00% |
|